Thursday, February 4, 2021

NOSI: Urgent Competitive Revisions, Administrative Supplements for SARS-CoV-2 Vaccine Hesitancy, Uptake Research at RCMI U54s

Urgent Competitive Revisions and Administrative Supplements for SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation Research at NIMHD R

Having trouble viewing this email? View it as a Web page.

Updates

NIMHD NOSI: Notice of Special Interest

Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation

NIH Guide Number: NOT-MD-21-012

Open Date: February 4, 2021

First Application Date: March 5, 2021

View NOT-MD-21-012


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute on Minority Health and Health Disparities · 6707 Democracy Boulevard · Suite 800 · Bethesda, MD · 20892-5465 GovDelivery logo

No comments:

Post a Comment

Private investors pour $50 billion into booming sector… investment opportunity

Unstoppable megatrend driven by hundreds of billions in government spending ...